Ping Yeh

Title: Innovations in Cancer Treatment by Inventor Ping Yeh

Introduction

Ping Yeh is a notable inventor based in King of Prussia, PA (US), recognized for his contributions to cancer treatment through innovative methods. He holds two patents that focus on the application of human interleukin-18 (IL-18) polypeptides in therapeutic contexts. His work has the potential to significantly impact the field of oncology.

Latest Patents

Ping Yeh's latest patents include a method of treating cancer by administering conjugates comprising human IL-18 and substitution mutants thereof. This method involves the use of human interleukin-18 polypeptides that are conjugated to water-soluble polymers at specific sites on the IL-18 protein. These conjugated forms retain biological activity and demonstrate enhanced properties compared to their unconjugated counterparts. The second patent focuses on the conjugation of human IL-18 and its substitution mutants to water-soluble polymers, further emphasizing the innovative approach to cancer treatment.

Career Highlights

Throughout his career, Ping Yeh has worked with prominent companies such as SmithKline Beecham Corporation and GlaxoSmithKline LLC. His experience in these organizations has contributed to his expertise in the field of biopharmaceuticals and cancer research.

Collaborations

Ping Yeh has collaborated with notable professionals in his field, including Narendra B Bam and Jacob Bongers. These collaborations have likely enriched his research and development efforts.

Conclusion

Ping Yeh's innovative work in the treatment of cancer through the application of human IL-18 polypeptides showcases his significant contributions to medical science. His patents reflect a commitment to advancing therapeutic methods that could improve patient outcomes.